MarketResearch.biz has recently published a market research report titled, “Global Glucagon Market by Type, by Application, and by Region – Global Forecast from 2020 to 2029”. The report offers a detailed analysis of the global glucagon market. It is through systematic and exhaustive research efforts, both primary and secondary, as well as ideal segmentation that the research results have been gleaned over the study period. The report also presents the first five-year cumulative revenue (2020 – 2024), which is projected to be valued at more than US$ 2.5 Billion, and this is expected to increase moderately over the latter part of the five-year forecast period.
Glucagon: Product Types
Inject Glucagon: Glucagon injection is an emergency drug used to treat severe hypoglycemia (low blood sugar) in diabetic patients, treated with insulin.
Nasal Glucagon: Nasal glucagon increases blood sugar levels in the body by stimulating the liver to release stored glucose into the bloodstream.
Browse the full “Global Glucagon Market By Type, By Application, And By Region – Global Forecast From 2020 To 2029” report at https://marketresearch.biz/report/glucagon-market/
Global Glucagon Market: Dynamics
Inclining incidence of hypoglycemia among patients suffering from diabetes, growing geriatric population, increasing number of drug approvals by USFDA and products in pipeline are some of the major factors expected to drive growth of the market. For instance, in July 2019, FDA approved the first-ever non-injectable emergency glucagon – Nasal glucagon powder – developed and marketed by Eli Lilly and Company under the brand name – Baqsimi. The treatment was approved to use for people with diabetes, and age of 4 and above. The US list price for a BAQSIMI one-pack is US$ 280.8 and for a two-pack is US$ 561.6.
Trends: A recent trend observed in the global glucagon market is the availability of mini-dose glucagon or rescue glucagon kits. A new automated drug delivery system is a trend observed in the market. According to a study in New Orleans, which held on March 25, 2019, a new automated drug delivery system help prevent severe hypoglycemia in patients who have undergone bariatric surgery. New delivery option for the administration of glucagon during hypoglycemic events can make the process much easier for diabetic patients, especially children, and their caregivers.
Based on the region, North America market is estimated to account for the highest revenue share and is projected to dominate the glucagon market in the future, followed by Europe. This is attributable to rising prevalence of hypoglycemia in patients with high glucose levels / diabetes, changing lifestyle patterns, and increasing demand for glucagon, especially among diabetic and elderly population.
Global Glucagon Market: Market Forecast
The comprehensive research report comprises a complete forecast of the global glucagon market based on factors affecting the market and their impact in the foreseeable future. According to the forecast projections, revenue from the global glucagon market is expected to register a CAGR of 6.2% over the 10-year forecast period.
Global Glucagon Market: Segmental Snapshot
The market report has been segmented on the basis of type, application, and region. The type segment includes kits, injection, and powder/solution. The application segment includes emergency use, general use, diagnostic & motility, cardiogenic shock, and other applications. Regions include North America, Europe, Asia Pacific, South America, and Middle East & Africa.
Type: The powder/solution segment is projected to register comparatively higher CAGR of more than 6.3%, followed by the kits segment in the global glucagon market
Application: The diagnostic & motility segment is projected to record higher CAGR of more than 6.8% in terms of revenue in the global market, followed by the emergency use segment
Region: The Asia Pacific glucagon market is expected to register higher CAGR of more than 6.3% in the global glucagon market, followed by the markets in North America in terms of growth rate
Global Glucagon Market: Competitive Analysis
The global glucagon market research report includes company profiles of major players/ companies such as Novo Nordisk A/S, Eli Lilly & Company, Fresenius SE & Co. KGaA, Torrent Pharmaceuticals Ltd., Xeris Pharmaceuticals, Inc., Svar Life Science AB, and Taj Pharmaceuticals Ltd.
“Global Glucagon Market Report 2019: Industry Trends, Market Analysis, Market Size, Revenue Share, Market Opportunities, Key Players, Factors Driving, Segments, and Forecast 2020 – 2029” report has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the present scenario and the growth prospects of the global glucagon market for 2019–2029.
MarketResearch.biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. MarketResearch.biz offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations across the globe, and deliver our offerings in the shortest possible turnaround time.
Like us on Facebook: https://www.facebook.com/marketresearch.biz
Follow on Twitter+: https://twitter.com/PrudourResearch
420 Lexington Avenue, Suite 300
New York City, NY 10170,
Email ID: email@example.com